Replies to post #201478 on Avid Bioservices Inc (CDMO)

[InternetForumUser]

I have read that the time to get into PPHM is NOW for almost exactly 2 years now.

There have been many examples posted here about other Biotechs who seem to be valued much higher with what seems to be less potential than Bavituximab.

At what point will PPHM be valued higher? Will the valuation depend solely on the P3?

Will the Liver Results provide some value for the shareholders?